The Leadership Team at Biohaven Pharmaceuticals is responsible for setting the strategic direction and oversight of the company’s research and development initiatives focused on the glutamatergic system. Comprising top executives from various disciplines, including R&D, medical affairs, and commercial strategy, the team collaborates to drive innovative drug development, ensure regulatory compliance, and establish partnerships that enhance the company's market position and growth potential. Their efforts are crucial in advancing clinical programs and bringing novel therapies to patients suffering from neurological disorders.
View all